Professional Activities:

Current Position: Arthur and Rosalie Kaplan Professor and Chair of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, Duarte, California, 2012-
Interim Deputy Director, Clinical Research, City of Hope Comprehensive Cancer Center (NCI-designated), 2012-2013
Previous Positions:  Senior Staff Fellow: National Cancer Institute, Bethesda, Maryland, 20892, 1988-90.

• Assistant Professor of Medicine (7/90-12/95)
• Assistant Professor of Medicine and Pharmacology (7/92-12/95):
• Associate Professor of Pharmacology and Medicine (1/96-3/03).
• Columbia University, College of Physicians and Surgeons
• Professor of Medicine and Molecular Pharmacology
• Albert Einstein College of Medicine, Bronx, NY 10467
• Director, Medical Genitourinary Oncology
• Attending Physician
• Montefiore Medical Center, Bronx, NY 10467 (3/03-3/12)
• Diplomate, American Board of Internal Medicine, (1986)
• Diplomate, American Board of Oncology (1987)

Awards

American Cancer Society, Clinical Career Development Award (1992-1995)

Honors:

• Irving Assistant Professor of Medicine and Pharmacology, Columbia University (1993-1996)
• American Society for Clinical Investigation (1996)
• Who’s Who in America (Marquis, 2010-15)
• Who’s Who in the World (Marquis, 2011, 13-15)
• Top Doctors in the LA Area (Oncology), Pasadena Magazine 2013, 14
• Top Doctors in Los Angeles (Oncology), Hollywood Reporter 2014
• Best Doctors in New York, New York Magazine, 2008-9 (prostate cancer), 2011-12 (prostate and bladder cancer)
• New York’s “Superdoctors” (top 5%), New York Times Magazine, 2008-9
• Best Doctors in the NY Metro Area (2004-11), Castle Connolly Medical Ltd., publisher
• European Journal of Pharmaceutics and Biopharmaceutics, best paper of 1999 (2000)
• America’s Top Doctors for Cancer, Castle Connolly Medical Ltd. (2013, 14)
• Faculty of 1000 Biologists Selection (Nov., 2009; paper #116 in bibliography), cited as  “exceptional”, with F1000 factor 9.0, 5th highest of all currently reviewed papers.  Ranked #1 in “Hidden Jewels”

Co-Editor-in-Chief: Oligonucleotides 1993-2011 (formerly Antisense and Nucleic Acid Drug Development and Antisense Research and Development; Mary-Ann Liebert Publishers)

Series Editor:  Perspectives in Antisense Science (Kluwer Academic Publishers; four volumes published)

Editorial Advisory Boards:

• Associate Editor: Cancer Gene Therapy (Stockton Press)
• Molecular Cancer Therapeutics (American Association for Cancer Research)
• Clinical Cancer Research (American Association for Cancer Research)
• Molecular Therapy (American Society for Gene Therapy)

Current Scientific Advisory Boards and Consultancies:

Santaris (Copenhagen, DK); Nanoviricides (West Haven, CT); iCeutica (King of Prussia, PA)
National PI:  Phase III trial of Solumatrixabiraterone acetate + methylprednisolone vs. Abiraterone + prednisone (sponsored by iCeutica)

Former Consulting Chief Medical Officer, Tokai Pharmaceuticals (2009-10, Cambridge, MA) Lead compound, currently in a Phase 1/2 clinical trial is TOK-001 for castrate-resistant prostate cancer.

Professional Organizations:

• American  Society for Clinical Oncology
• American Association for Cancer Research
• American Society for Gene Therapy (Oligonucleotide Therapeutics Committee, 2005-2008)